Association Between Selective Serotonin Reuptake Inhibitor Use and erious Upper Gastrointestinal Bleeding

[1]  J. Sareen,et al.  Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding , 2009, The American Journal of Gastroenterology.

[2]  F. D. de Abajo,et al.  Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. , 2008, Archives of general psychiatry.

[3]  S. Suissa,et al.  Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. , 2008, British journal of clinical pharmacology.

[4]  A. Localio,et al.  Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity , 2008, Pharmacoepidemiology and drug safety.

[5]  X. Vidal,et al.  Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants , 2008, Drug safety.

[6]  K. Borch-Johnsen,et al.  Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[7]  D. Atar,et al.  Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study , 2007, Neuropsychopharmacology.

[8]  R. Huupponen,et al.  Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population , 2007, European Journal of Clinical Pharmacology.

[9]  Á. Lanas,et al.  Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations , 2006, Gut.

[10]  J. Hallas,et al.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study , 2006, BMJ : British Medical Journal.

[11]  M. Crowell,et al.  Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis , 2006, Alimentary pharmacology & therapeutics.

[12]  R. Hubbard,et al.  Does concurrent prescription of selective serotonin reuptake inhibitors and non‐steroidal anti‐inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? , 2005, Alimentary pharmacology & therapeutics.

[13]  C. Barbui,et al.  Antidepressant drug use in Lombardy, Italy: a population-based study. , 2004, Journal of affective disorders.

[14]  A. Egberts,et al.  Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. , 2004, Archives of internal medicine.

[15]  A. Egberts,et al.  Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. , 2003, Archives of internal medicine.

[16]  J. Hallas,et al.  Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study , 2003, BMJ : British Medical Journal.

[17]  J. Olsen,et al.  Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. , 2003, Archives of internal medicine.

[18]  K. Chu,et al.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. , 2002, The New England journal of medicine.

[19]  J. Hallas,et al.  Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study , 2002, Stroke.

[20]  J. Atherton,et al.  Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding , 2002, Alimentary pharmacology & therapeutics.

[21]  K. Rothman.  Epidemiology: An Introduction , 2002 .

[22]  J. Hallas,et al.  Selective Serotonin Reuptake Inhibitors and the Risk of Stroke , 2002 .

[23]  C. van Walraven,et al.  Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study , 2001, BMJ : British Medical Journal.

[24]  J. Williams,et al.  IN A POPULATION-BASED CASE-CONTROL STUDY , 2001 .

[25]  Robert West,et al.  Smoking cessation guidelines for health professionals: an update , 2000, Thorax.

[26]  S. Brannan,et al.  Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. , 2000, The international journal of neuropsychopharmacology.

[27]  O. Bonnevie,et al.  Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. , 2000, Epidemiology.

[28]  J. Feely,et al.  Association between SSRIs and upper gastrointestinal bleeding. Coprescription of antiulcer drugs with SSRIs is fairly common. , 2000, BMJ.

[29]  G. Pearce,et al.  Association between SSRIs and upper gastrointestinal bleeding , 2000, BMJ : British Medical Journal.

[30]  L Frank,et al.  When an Entire Country Is a Cohort , 2000, Science.

[31]  J. LeLorier,et al.  Expressing the magnitude of adverse effects in case-control studies: “the number of patients needed to be treated for one additional patient to be harmed” , 2000, BMJ : British Medical Journal.

[32]  M. Rawlins,et al.  Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs , 2000, Gut.

[33]  M Maclure,et al.  Should we use a case-crossover design? , 2000, Annual review of public health.

[34]  S. Shapiro,et al.  The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption , 1999, American Journal of Gastroenterology.

[35]  F. D. de Abajo,et al.  Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study , 1999, BMJ.

[36]  P. Hjemdahl,et al.  Effects of serotonin on platelet activation in whole blood , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[37]  H. Sørensen,et al.  The Danish prescription registries. , 1997, Danish medical bulletin.

[38]  J. Kurata,et al.  Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. , 1997, Journal of clinical gastroenterology.

[39]  C P Farrington,et al.  Case series analysis of adverse reactions to vaccines: a comparative evaluation. , 1996, American journal of epidemiology.

[40]  T. M. Brown,et al.  Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. , 1996, Psychosomatics.

[41]  Moride Yola,et al.  Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. , 1994 .

[42]  Y. Moride,et al.  Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. , 1994, Journal of clinical epidemiology.

[43]  M. Åsberg,et al.  Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. , 1990, Journal of affective disorders.